Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Gustavo A. Angarita, Hasti Hadizadeh, Ignacio Cerdena & Marc N. Potenza. (2021) Can pharmacotherapy improve treatment outcomes in people with co-occurring major depressive and cocaine use disorders?. Expert Opinion on Pharmacotherapy 22:13, pages 1669-1683.
Read now
Read now
Gerardo Gonzalez, Alan Feingold, Alison Oliveto, Kishor Gonsai & Thomas R. Kosten. (2003) Comorbid Major Depressive Disorder as a Prognostic Factor in Cocaine‐Abusing Buprenorphine‐Maintained Patients Treated with Desipramine and Contingency Management. The American Journal of Drug and Alcohol Abuse 29:3, pages 497-514.
Read now
Read now
Vanessa Crawford, Ilana B. Crome & Carmel Clancy. (2003) Co-existing Problems of Mental Health and Substance Misuse (Dual Diagnosis): a literature review. Drugs: Education, Prevention and Policy 10:1, pages 1-74.
Read now
Read now
Bruce J. Rounsaville, Roger Weiss, Kathleen Carroll. (1999) Options for Managing Psychotropic Medications in Drug-Abusing Patients Participating in Behavioral Therapies Clinical Trials. American Journal on Addictions 8:3, pages 178-189.
Read now
Read now
Adam Silk & Howard Shaffer. (1996) Dysthymia, Depression, and a Treatment Dilemma in a Patient with Polysubstance Abuse. Harvard Review of Psychiatry 3:5, pages 279-284.
Read now
Read now
Articles from other publishers (34)
Wojciech Danysz, Andrzej Dekundy, Astrid Scheschonka & Peter Riederer. (2021) Amantadine: reappraisal of the timeless diamond—target updates and novel therapeutic potentials. Journal of Neural Transmission 128:2, pages 127-169.
Crossref
Crossref
Inara F. Raupp-Barcaro, Maria A. Vital, José C. Galduróz & Roberto Andreatini. (2018) Potential antidepressant effect of amantadine: a review of preclinical studies and clinical trials. Revista Brasileira de Psiquiatria 40:4, pages 449-458.
Crossref
Crossref
Renato B. Pereira, Paula B. Andrade & Patrícia Valentão. (2015) A Comprehensive View of the Neurotoxicity Mechanisms of Cocaine and Ethanol. Neurotoxicity Research 28:3, pages 253-267.
Crossref
Crossref
Marie-Line Reynaert, Jordan Marrocco, Eleonora Gatta, Jérôme Mairesse, Gilles Van Camp, Francesca Fagioli, Stefania Maccari, Ferdinando Nicoletti & Sara Morley-Fletcher. 2015. Perinatal Programming of Neurodevelopment. Perinatal Programming of Neurodevelopment
101
120
.
Ross M. Colquhoun. (2013) Open Label Trial of Naltrexone Implants: Measuring Blood Serum Levels of Naltrexone. Substance Abuse: Research and Treatment 7, pages SART.S10776.
Crossref
Crossref
Pier Paolo Pani, Emanuela Trogu, Simona Vecchi & Laura Amato. (2011) Antidepressants for cocaine dependence and problematic cocaine use. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Catherine G. Sutcliffe, Danielle German, Bangorn Sirirojn, Carl Latkin, Apinun Aramrattana, Susan G. Sherman & David D. Celentano. (2009) Patterns of methamphetamine use and symptoms of depression among young adults in northern Thailand. Drug and Alcohol Dependence 101:3, pages 146-151.
Crossref
Crossref
Bridget Candy, Louise Jones, Rachael Williams, Adrian Tookman & Michael King. (2008) Psychostimulants for depression. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Neil E. Paterson & Athina Markou. (2007) Animal models and treatments for addiction and depression co-morbidity. Neurotoxicity Research 11:1, pages 1-32.
Crossref
Crossref
Jianli Yang, Weihui Li, Xiaohua Liu, Zexuan Li, Hongying Li, Guifu Yang, Lin Xu & Lingjiang Li. (2006) Enriched environment treatment counteracts enhanced addictive and depressive-like behavior induced by prenatal chronic stress. Brain Research 1125:1, pages 132-137.
Crossref
Crossref
John Tsuang, Timothy W Fong & Edmond Pi. (2005) Pharmacological Treatment of Patients with Schizophrenia and Substance Abuse Disorders. Addictive Disorders & Their Treatment 4:4, pages 127-137.
Crossref
Crossref
David McDowell, Edward V. Nunes, Angela M. Seracini, Jami Rothenberg, Suzanne K. Vosburg, Guoguang J. Ma & Eva Petkova. (2005) Desipramine treatment of cocaine-dependent patients with depression: A placebo-controlled trial. Drug and Alcohol Dependence 80:2, pages 209-221.
Crossref
Crossref
Rebecca Dodge, Jody Sindelar & Rajita Sinha. (2005) The role of depression symptoms in predicting drug abstinence in outpatient substance abuse treatment. Journal of Substance Abuse Treatment 28:2, pages 189-196.
Crossref
Crossref
Douglas M. Ziedonis. (2014) Integrated Treatment of Co-Occurring Mental Illness and Addiction: Clinical Intervention, Program, and System Perspectives. CNS Spectrums 9:12, pages 892-904,925.
Crossref
Crossref
A. R. Lingford-Hughes, S. Welch & D. J. Nutt. (2016) Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 18:3, pages 293-335.
Crossref
Crossref
M. T. Abou-Saleh. (2014) Psychopharmacology of substance misuse and comorbid psychiatric disorders. Acta Neuropsychiatrica 16:1, pages 19-25.
Crossref
Crossref
Mary Ann Adler Cohen & César A. Alfonso. 2004. AIDS and Other Manifestations of HIV Infection. AIDS and Other Manifestations of HIV Infection
537
576
.
Eric D. Collins, Suzanne K. Vosburg, Carl L. Hart, Margaret Haney & Richard W. Foltin. (2003) Amantadine does not modulate reinforcing, subjective, or cardiovascular effects of cocaine in humans. Pharmacology Biochemistry and Behavior 76:3-4, pages 401-407.
Crossref
Crossref
Herbert D. Kleber. (2010) Pharmacologic Treatments for Heroin and Cocaine Dependence. The American Journal on Addictions 12:s2.
Crossref
Crossref
James R. McKay, Helen M. Pettinati, Rebecca Morrison, Michael Feeley, Francis D. Mulvaney & Robert Gallop. (2002) Relation of depression diagnoses to 2-year outcomes in cocaine-dependent patients in a randomized continuing care study.. Psychology of Addictive Behaviors 16:3, pages 225-235.
Crossref
Crossref
Igor ElmanKatherine H. Karlsgodt, David R. Gastfriend, Christopher F. Chabris & Hans C. Breiter. (2016) Cocaine-primed craving and its relationship to depressive symptomatology in individuals with cocaine dependence. Journal of Psychopharmacology 16:2, pages 163-167.
Crossref
Crossref
David M McDowell & Reynolds C Clodfelter. (2001) Depression and Substance Abuse: Considerations of Etiology, Comorbidity, Evaluation, and Treatment. Psychiatric Annals 31:4, pages 244-251.
Crossref
Crossref
Grace O’Leary & Roger D. Weiss. (2000) Pharmacotherapies for cocaine dependence. Current Psychiatry Reports 2:6, pages 508-513.
Crossref
Crossref
Mary Ann Adler Cohen & Jeffrey M. Jacobson. (2000) Maximizing life’s potentials in AIDS: A psychopharmacologic update. General Hospital Psychiatry 22:5, pages 375-388.
Crossref
Crossref
Adam Bisaga & Piotr Popik. (2000) In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-d-aspartate (NMDA) antagonists. Drug and Alcohol Dependence 59:1, pages 1-15.
Crossref
Crossref
KEVIN A. SEVARINO, ALISON OLIVETO & THOMAS R. KOSTEN. (2006) Neurobiological Adaptations to Psychostimulants and Opiates as a Basis of Treatment Development. Annals of the New York Academy of Sciences 909:1, pages 51-87.
Crossref
Crossref
Jason Uslaner, Ari Kalechstein, Todd Richter, Walter Ling & Thomas Newton. (1999) Association of Depressive Symptoms During Abstinence With the Subjective High Produced by Cocaine. American Journal of Psychiatry 156:9, pages 1444-1446.
Crossref
Crossref
Leanne D. Mitchem, C.K. Kruschel, E. Dallman, Katie A. Anders, Megan Czapiga, John J. Panos & Rhea E. Steinpreis. (1999) The Effects of the Naltrexone Implant on Rodent Social Interactions and Cocaine-Induced Conditioned Place Preference. Pharmacology Biochemistry and Behavior 62:1, pages 97-102.
Crossref
Crossref
RICHARD S. SCHOTTENFELD, JULIANA R. PAKES & THOMAS R. KOSTEN. (1998) Prognostic Factors in Buprenorphine- versus Methadone-Maintained Patients. The Journal of Nervous & Mental Disease 186:1, pages 35-43.
Crossref
Crossref
M. Elena Denison, Alfonso Paredes, Shana Bacal & Frank H. Gawin. 1998. Handbook of Substance Abuse. Handbook of Substance Abuse
201
213
.
Maxine L Stitzer & Sharon L Walsh. (1997) Psychostimulant Abuse: The Case for Combined Behavioral and Pharmacological Treatments. Pharmacology Biochemistry and Behavior 57:3, pages 457-470.
Crossref
Crossref
Douglas Ziedonis & Kathleen Brady. (1997) DUAL DIAGNOSIS IN PRIMARY CARE. Medical Clinics of North America 81:4, pages 1017-1036.
Crossref
Crossref
Richard B. Rothman & John R. Glowa. (1995) A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Molecular Neurobiology 11:1-3, pages 1-19.
Crossref
Crossref
Surita Rao, Douglas Ziedonis & Thomas Kosten. (1995) The Pharmacotherapy of Cocaine Dependence. Psychiatric Annals 25:6, pages 363-368.
Crossref
Crossref